Investors & shareholders

Analysts coverage

Inicio » Investors & shareholders » Analysts coverage

Analysts coverage

 

 

AnalystMonthRecommendationTarget Price (1)
SantanderMarch 2019Buy
Ahorro CorporaciónMay 2019Buy3,80
NorbolsaMay 2019Buy3,81
GVC GaescoJuly 2019Buy3,70
BBVAJuly 2019Overweight3,80
MirabaudJuly 2019Buy3,50
CheuvreuxJuly 2019Buy3,30
JB Capital MarketsJuly 2019Buy4,00
FidentiisJuly 2019Buy3,50
BPIJuly 2019Buy3,90

 

(1) Euros per share

WORLDWIDE

PRESENCE

TUBACEX presents its results in a market context dominated by COVID-19

2019 has marked a turning point for recovery as TUBACEX order intake demonstrates. Although far from pre-crisis levels it has experienced an increase of 30% in relation to the previous year. This gradual and general market recovery is also enabling operating leverage ratios to be maintained for all business units and therefore, achieving double-digit consolidated margins.

read more

TUBACEX announces consolidated results and ends 2019 with an EBITDA of €67.1 million

2019 has marked a turning point for recovery as TUBACEX order intake demonstrates. Although far from pre-crisis levels it has experienced an increase of 30% in relation to the previous year. This gradual and general market recovery is also enabling operating leverage ratios to be maintained for all business units and therefore, achieving double-digit consolidated margins.

read more